Brain Stimulation + Cognitive Training for Mild Traumatic Brain Injury
(COGNETRIC Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores a new home-based method to improve attention in individuals with a history of mild traumatic brain injury (mTBI), focusing specifically on active-duty service members and veterans. The study employs a brain stimulation technique called RS-tDCS+ (Remotely Supervised Transcranial Direct Current Stimulation combined with Cognitive Training) to enhance learning and reorganize brain connections. Participants will receive either the real treatment or a sham (placebo) version to determine any differences in attention improvement. The trial seeks individuals who experienced mTBI at least three months ago and face attention or concentration difficulties in daily life. As an unphased trial, this study provides a unique opportunity to contribute to innovative research that may enhance cognitive recovery methods.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications. However, if you have been newly prescribed a medication within the last 3 weeks, you may not be eligible to participate.
What prior data suggests that this brain stimulation technique is safe for cognitive rehabilitation?
Research has shown that transcranial direct current stimulation (tDCS), including the remotely supervised version (RS-tDCS), is generally safe. Participants in studies have tolerated RS-tDCS well, with few negative effects reported. Specifically, a review of several trials found that side effects were rare and minor, with most people experiencing only mild sensations like tingling on the scalp.
One study used RS-tDCS at home and found it both safe and effective, particularly for improving symptoms in various conditions. This suggests that the treatment is suitable for use outside a medical setting, offering convenience without compromising safety.
Overall, while no treatment is completely risk-free, RS-tDCS has demonstrated a good safety record in various studies, making it a promising option for cognitive rehabilitation in mild traumatic brain injury.12345Why are researchers excited about this trial?
Researchers are excited about this treatment because it combines cognitive training with transcranial direct current stimulation (tDCS), a unique approach for addressing mild traumatic brain injury (mTBI). Unlike traditional options, which often rely on medications or cognitive therapies alone, this method uses a non-invasive technique to stimulate specific brain areas, potentially enhancing recovery. The remotely supervised tDCS+ allows patients to receive treatment at home, making it more accessible and convenient. This novel combination could lead to faster and more effective improvements in cognitive function, a significant advantage over existing therapies.
What evidence suggests that RS-tDCS+ is effective for improving complex attention in mTBI?
Research shows that Remotely Supervised Transcranial Direct Current Stimulation with Cognitive Training (RS-tDCS+) may improve attention in people with mild traumatic brain injury (mTBI). In this trial, participants will join either an active tDCS group or a sham tDCS group. Studies have found that tDCS can boost learning and help the brain form new connections, potentially enhancing thinking skills. While evidence is still growing, some research suggests it could also benefit similar conditions, such as multiple sclerosis. Early results are promising, but more research is needed to confirm its effectiveness specifically for mTBI.14678
Who Is on the Research Team?
Lars D Hungerford, PhD
Principal Investigator
United States Naval Medical Center, San Diego
Are You a Good Fit for This Trial?
This trial is for Active Duty Service Members and Veterans who have experienced mild Traumatic Brain Injury (mTBI) and are struggling with complex attention issues. Participants should be interested in a home-based cognitive rehabilitation program using brain stimulation and cognitive training.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive 10 sessions of cognitive training combined with transcranial direct current stimulation (RS-tDCS) over 2 weeks, conducted remotely at home.
Post-Treatment Assessment
Participants undergo post-intervention assessments including EEG and MRI to evaluate changes in brain connectivity and function.
Follow-up
Participants are monitored for safety and effectiveness after treatment, with assessments at 1 and 6 weeks post-treatment.
What Are the Treatments Tested in This Trial?
Interventions
- Remotely Supervised tDCS+
Trial Overview
The study tests 'Remotely Supervised Transcranial Direct Current Stimulation combined with Cognitive Training' (RS-tDCS+), comparing active brain stimulation to sham (placebo). It aims to improve attention by enhancing learning and the brain's adaptability, measured through various tests over time.
How Is the Trial Designed?
2
Treatment groups
Experimental Treatment
Placebo Group
Participants will receive 10 sessions of cognitive training concurrent with transcranial direct current stimulation. Stimulation will be applied for 20 minutes at the beginning of each session. Current will be ramped from 0 mA to 2 mA over 30 seconds, and then ramped down from 2 mA to 0 mA at the end of 20 minutes. Current will be applied via two electrodes consisting of a pre-inserted carbon rubber snap electrode that is pre-saturated with saline and connects directly to designated electrode sites located on the tDCS headband. The anodal stimulating electrode will be at location F3 (based on the 10-20 EEG location system) and the cathodal electrode at location F4.
Electrodes will be placed at the same positions as for active stimulation (F3 and F4), but current will be ramped down immediately after the initial 30s ramp up period and then at 20 minutes ramped up and down as done at the beginning. Thus, participants feel the initial tingling sensation associated with tDCS, but will receive no active current for the rest of the stimulation period
Find a Clinic Near You
Who Is Running the Clinical Trial?
United States Naval Medical Center, San Diego
Lead Sponsor
The Defense and Veterans Brain Injury Center
Collaborator
Minneapolis Veterans Affairs Medical Center
Collaborator
University of Minnesota
Collaborator
Center for Veterans Research and Education
Collaborator
General Dynamics Information Technology
Collaborator
United States Department of Defense
Collaborator
Published Research Related to This Trial
Citations
Transcranial Direct Current Stimulation as a Treatment Tool ...
Based on the review, there is limited evidence of tDCS improving cognitive and motor performance. Surprisingly, there were only three studies that used tDCS in ...
2.
clinicaltrial.be
clinicaltrial.be/en/details/436402?per_page=20&only_recruiting=0&only_eligible=0&only_active=0Remotely Supervised tDCS+ for Complex Attention in mTBI ...
This multi-site study will investigate remotely-supervised tDCS (RS-tDCS) combined with cognitive training in the chronic phase of recovery (≥3 ...
Remotely Supervised tDCS+ for Complex Attention in mTBI ...
This multi-site study will investigate remotely-supervised tDCS (RS-tDCS) combined with cognitive training in the chronic phase of recovery (≥3 ...
Remotely Supervised Transcranial Direct Current Stimulation ...
Telerehabilitation using RS-tDCS combined with CT may lead to improved outcomes in MS. Keywords: Cognitive, multiple sclerosis, remotely supervised, tDCS, ...
Brain Stimulation + Cognitive Training for Mild Traumatic ...
The proposed study will evaluate a new approach to cognitive rehabilitation of mTBI using a brain stimulation technique called "Remotely Supervised ...
Remotely Supervised tDCS for Persistent Post-traumatic ...
The aim of this study is to evaluate the feasibility and efficacy of transcranial Direct Current Stimulation (tDCS) administered at home with real-time ...
Tolerability and feasibility of at-home remotely supervised ...
We analyzed tolerability (i.e., adverse events, AEs) reported in six Class I/II/III trials using RS-tDCS to study symptom outcomes over 10 to 60 daily ...
8.
frontiersin.org
frontiersin.org/journals/human-neuroscience/articles/10.3389/fnhum.2025.1552387/fullTranscranial direct current stimulation in individuals with ...
The aim of this study is to report clinical cases of patients with severe traumatic brain injury (TBI) who underwent transcranial direct current stimulation ( ...
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.